StockWatch
·

Suven Pharmaceuticals Ltd Q1 FY26 Results

COHANCEQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue549.3136.6%
Total Income563.4836.6%
Expenditure492.6236.5%
PBT62.7621.6%
Net Profit46.4019.8%
OPM18.92%0.62pp
NPM8.23%1.16pp
EPS1.2822.4%
View full financials

Informational and educational content only. Not investment advice.